CD44 and neoplasm: As shown in Figure 4, after 8 consecutive weeks of treatment, the tumor weight in model CD44+ mice was significantly higher than that in model CD44− mice (P < 0.05), in addition, a comparison between the β-elemene-treated groups and the model CD44+ group was significantly different except for the 25 mg/kg group (P > 0.05).